Antenatal administration of aminopropylidene diphosphonate.-Reference-Cited by-同舟云学术

Antenatal administration of aminopropylidene diphosphonate.

Published:1990-11-01 Issue:11 Volume:49 Page:955-955
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Annals of the Rheumatic Diseases

Author:

Dunlop D J,Soukop M,McEwan H P

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference2 articles.

1. Comparison of APD, Mithramycin and corticosteroids/calcitonin in the treatment ofcancerassociated hypercalcaemia;H, Ralston S.; J, Dryburgh F.; A, Cowan R.; D, Gardner M.; S, Jenkins A.; T, Boyle I.;Lancet,1985

2. Effect of single high dose infusions of APD on hypercalcaemia caused by cancer;J, Cantwell B.M.; L, Harris A.;BrMedJ,1987

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple sclerosis and the risk of infection: Association of British Neurologists consensus guideline;Practical Neurology;2022-07-21

2. Pamidronate Administration During Pregnancy and Lactation Induces Temporal Preservation of Maternal Bone Mass in a Mouse Model of Osteogenesis Imperfecta;Journal of Bone and Mineral Research;2019-10-09

3. Clinical evidence of the effect of bisphosphonates on pregnancy and the infant;Hormone Molecular Biology and Clinical Investigation;2019-09-20

4. Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study;Osteoporosis International;2018-08-31

5. Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations;Pediatric Drugs;2017-03-13